Nasolabial folds are not just a wrinkle.
They are the lines that run from the sides of the nose toward the corners of the mouth, but their depth can come from several things at once: cheek volume loss, midface descent, facial movement, skin thinning, sun damage, weight change, dental structure, and inherited anatomy.
That is why "fillers for nasolabial folds" is the wrong question if it means "will one syringe fix this?"
The better question is: what is causing this fold, what product would be placed where, and what is the plan if swelling, asymmetry, vascular compromise, nodules, infection, or an unnatural result happens?
What filler can and cannot do
Dermal fillers are gel-like substances injected under the skin. The U.S. Food and Drug Administration regulates dermal fillers as medical devices and describes them as implants used to create a smoother or fuller appearance. The FDA specifically lists nasolabial folds among approved uses for certain dermal fillers in adults 22 and older. [1]
That does not mean every fold should be filled directly.
| If the fold is mainly from... | What the consultation should decide |
|---|---|
| Cheek volume loss | Whether cheek support, not fold injection alone, is the better target. |
| A true crease at the fold | Whether a small amount of appropriate filler can soften the line. |
| Skin laxity | Whether tightening, laser, surgery, or no procedure fits better than filler. |
| Dryness or fine texture | Whether barrier repair, sunscreen, retinoids, or procedures fit before filler. |
| Pigment or sun damage | Whether the diagnosis is melasma, lentigines, actinic damage, or a lesion needing evaluation. |
| Weight or dental change | Whether volume, bite, dentures, or weight history is driving the appearance. |
Fillers can replace or redirect volume. They cannot tighten loose skin like surgery, resurface photoaging like some lasers, treat melasma, diagnose a spot, or reverse menopause-related skin change.
For broader options, see skin tightening treatment for face after menopause. For the non-injectable hyaluronic acid question, see oral hyaluronic acid after menopause.
What the evidence supports
Hyaluronic acid fillers have a real evidence base for nasolabial-fold correction, but the evidence does not support treating the category as one interchangeable product.
A 2022 meta-analysis reviewed 22 randomized controlled trials with 1,848 subjects comparing monophasic and biphasic hyaluronic acid fillers for aesthetic nasolabial-fold correction. It found greater and more durable nasolabial-fold severity improvement with monophasic fillers at multiple follow-up points, including 24 and 52 weeks, and a lower rate of post-injection pain. Other post-injection adverse events did not differ statistically. [5]
That is useful, but it answers a product-type comparison. It does not prove that any filler, in any injector's hands, is the right answer for every fold.
More recent split-face trials show how product-specific the evidence is.
In a 2024 prospective split-face, randomized, investigator- and subject-blinded trial, 45 people with moderate-to-severe symmetrical nasolabial folds received EST LF on one side and Restylane Lidocaine on the other, with nine months of follow-up. EST LF met noninferiority at month one, showed significant differences at three and six months on some measures, and both treatments were well tolerated. [6]
A 2026 double-blind, randomized, split-face trial enrolled 74 participants with moderate-to-severe nasolabial folds and compared Curea with Juvederm over 24 weeks. Curea improved Wrinkle Severity Rating Scale scores from 3.16 at baseline to 2.59 at week 24, met the trial's noninferiority margin against Juvederm, and had similar satisfaction and safety profiles with only mild, transient local reactions reported. [7]
The practical evidence limit is straightforward: fillers can work for selected folds, but studies are usually product-specific, anatomy-specific, and follow people for months, not forever.
The FDA safety boundary matters
The FDA describes dermal fillers as medical device implants. Most FDA-approved fillers are temporary because the body eventually breaks them down and absorbs them, and repeat procedures may be needed to maintain the result. [1]
The safety conversation should be more serious than "quick lunchtime procedure."
Common risks include bruising, redness, swelling, pain, tenderness, itching, and rash. Less common risks include inflammation, nodules or granulomas, infection, open or draining wounds, allergic reaction, and tissue death. The FDA also lists rare reports of severe allergic reaction, filler migration, leakage or rupture, permanent hard nodules, blood-supply injury, blindness, stroke, and death. [1]
The most serious risk is accidental injection into a blood vessel. The FDA says filler that enters a blood vessel can cause tissue death, stroke, or blindness, and complications may be serious and permanent. [2]
A 2025 systematic review and meta-analysis of vascular occlusions after dermal filler injections found that hyaluronic acid was the most frequently used filler among reported events, at 61.3 percent, and that complex vascular regions such as the glabella, nose, and nasolabial folds were commonly implicated. The authors reported that delays beyond five days correlated with permanent deficits and that hyaluronidase use in hyaluronic-acid-related occlusions had an 84.2 percent partial or total recovery rate in the analyzed reports. [8]
That does not mean nasolabial filler is off-limits. It means the injector needs anatomy skill, emergency recognition, and an on-site or immediate referral plan.
Why menopause changes the filler decision
Menopause does not make fillers automatically better or worse.
It changes the face around the fold. A 2025 narrative review describes menopause-related skin changes such as decreased collagen production, reduced elasticity, moisture loss, dryness, and wrinkling. The same review notes that few aesthetic studies analyze outcomes by menopausal status or hormone therapy use. [9]
That matters because the nasolabial fold may be only one visible part of the change.
| Midlife factor | Why it matters before filler |
|---|---|
| Dry, reactive skin | Bruising, swelling, retinoid irritation, and barrier damage can change timing and aftercare. |
| Pigment history | Post-inflammatory hyperpigmentation can follow bruising or inflammation. |
| Weight change | Recent weight loss can deepen folds and may keep changing the face. |
| Dental or bite changes | Dentures, tooth loss, or bite changes can affect mouth support. |
| Prior filler or threads | Product type, location, and timing change the risk and plan. |
| Anticoagulants or supplements | Bruising and bleeding risk may change. |
| Active rashes or lesions | Diagnosis comes before cosmetic injection. |
A stronger consultation separates volume loss, laxity, skin quality, pigment, rosacea, acne scars, and medical lesions before choosing a syringe.
Who may be a reasonable candidate
Nasolabial-fold filler may fit a woman who has a stable fold driven by volume or support change, realistic expectations, no active infection or inflamed skin, and an injector who can explain the product, placement, expected duration, reversibility, and complication plan.
It is a weaker fit if the main concern is major sagging, heavy jowls, thin crepey skin, unstable weight change, untreated dental support issues, melasma, rough sun damage, active acne, rosacea flare, eczema, or a changing lesion.
It is also a poor fit when the consultation starts with a syringe count before explaining anatomy.
What to ask your clinician before paying
Ask:
- Is this fold mainly caused by volume loss, cheek descent, skin laxity, skin quality, dental support, or facial movement?
- Are you planning cheek support, fold injection, or both?
- What exact filler will you use, and is it FDA-approved for this type of use?
- Is the filler hyaluronic acid, calcium hydroxylapatite, poly-L-lactic acid, PMMA, collagen, or fat?
- If it is hyaluronic acid, do you keep hyaluronidase available, and what is your vascular-occlusion protocol?
- What injection depth, technique, and volume are planned?
- What result should I expect immediately, at two weeks, and at six months?
- What swelling, bruising, lumps, asymmetry, or delayed reactions should prompt a call?
- What should I avoid after treatment, including exercise, heat, massage, dental work, alcohol, supplements, or other procedures?
Red flags before or after filler
Delay filler if you have an active infection, inflamed skin, acne cyst, rash, hives, open wound, recent dental infection, severe allergy history, untreated bleeding disorder, recent facial procedure, uncertain prior filler material, keloid tendency, immune suppression, or a changing spot that needs diagnosis.
After filler, seek urgent medical advice for unusual or severe pain, skin blanching, gray-blue discoloration, mottled color, spreading redness, pus, fever, vision changes, severe headache, face drooping, numbness or weakness, trouble speaking, sudden asymmetry, or symptoms that feel wrong during or shortly after injection. The FDA specifically tells patients to seek immediate medical attention for unusual pain, vision changes, white, gray, or blue skin near the injection site, or stroke symptoms during or shortly after the procedure. [1]
Bottom line
Fillers for nasolabial folds can be evidence-based when the fold fits the treatment, the product matches the anatomy, and the injector has a real complication plan.
They should not be sold as a universal answer to menopause skin changes. The safer standard is diagnosis first, anatomy second, product and technique third, and a written plan for vascular risk, swelling, bruising, nodules, infection, asymmetry, and follow-up before anything is injected.
Related reading:
- Skin Tightening Treatment for Face After Menopause.
- Oral Hyaluronic Acid After Menopause.
- Radiofrequency Microneedling After Menopause.
- Menopause Skin Changes.
References
[1] U.S. Food and Drug Administration. Dermal Fillers (Soft Tissue Fillers). https://www.fda.gov/medical-devices/aesthetic-cosmetic-devices/dermal-fillers-soft-tissue-fillers
[2] U.S. Food and Drug Administration. Dermal Filler Do's and Don'ts for Wrinkles, Lips and More. https://www.fda.gov/consumers/consumer-updates/dermal-filler-dos-and-donts-wrinkles-lips-and-more
[3] American Academy of Dermatology. Fillers: FAQs. https://www.aad.org/public/cosmetic/wrinkles/fillers-faqs
[4] American Academy of Dermatology. Fillers: Preparation. https://www.aad.org/public/cosmetic/wrinkles/fillers-preparation
[5] Huang Y, Zhang Y, Fei X, Fan Q, Mao J. Monophasic and Biphasic Hyaluronic Acid Fillers for Esthetic Correction of Nasolabial Folds: A Meta-Analysis of Randomized Controlled Trials. Aesthetic Plast Surg. 2022;46(3):1407-1422. doi:10.1007/s00266-021-02729-y https://pubmed.ncbi.nlm.nih.gov/35066619/
[6] Lheritier C, Converset S, Rzany BJ, Cartier H, Ascher B. Efficacy of a New Hyaluronic Acid Dermal Filler on Nasolabial Folds Correction: A Prospective, Comparative, Double-Blinded Clinical Trial. Dermatol Surg. 2024;50(8):746-751. doi:10.1097/dss.0000000000004207 https://pubmed.ncbi.nlm.nih.gov/38713883/
[7] Kim BR, Shin JW, Kim DW, et al. Efficacy and Safety of New Hyaluronic Acid Filler for Nasolabial Fold Correction: A Double-Blind, Randomized Trial. Plast Reconstr Surg. 2026;157(2):249-256. doi:10.1097/prs.0000000000012320 https://pubmed.ncbi.nlm.nih.gov/40707029/
[8] Chakhachiro A, Waseem M. Risk Factor Analysis for Vascular Occlusions After Dermal Filler Injections: A Systematic Review and Meta-Analysis. Cureus. 2025;17(4):e82800. doi:10.7759/cureus.82800 https://pubmed.ncbi.nlm.nih.gov/40406769/
[9] Viscomi B, Muniz M, Sattler S. Managing Menopausal Skin Changes: A Narrative Review of Skin Quality Changes, Their Aesthetic Impact, and the Actual Role of Hormone Replacement Therapy in Improvement. J Cosmet Dermatol. 2025;24 Suppl 4(Suppl 4):e70393. doi:10.1111/jocd.70393 https://pubmed.ncbi.nlm.nih.gov/40847905/